Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting β2-agonists

Journal of Allergy and Clinical Immunology

Volumn 123, Issue 1, 2009, Pages

  Appleton, Sarah L ^a   Ruffin, Richard E ^a   Wilson, David H ^a   Taylor, Anne W ^b   Adams, Robert J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Population Research and Outcome Studies Unit   (Australia)

Author keywords

Adrenergic agonists; asthma; cardiovascular system; epidemiology; lung diseases; obstructive

Indexed keywords

CORTICOSTEROID; FORMOTEROL; LIPID; SALBUTAMOL; SALMETEROL; TERBUTALINE;

ANGINA PECTORIS; ANTHROPOMETRY; ARTICLE; ASTHMA; ATOPY; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONFIDENCE INTERVAL; COUGHING; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEART INFARCTION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SPIROMETRY; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 58149119494     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.10.032     Document Type: Article

References (51)

1. Beuther D., and Sutherland E. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 175 (2007) 661-666
2. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115 (2005) 911-919
3. Babu K., Davies D., and Holgate S. Role of tumor necrosis factor alpha in asthma. Immunol Allergy Clin North Am 24 (2004) 583-597
4. Lyon C.J., Law R.E., and Hsueh W.A. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144 (2003) 2195-2200
5. Andersson C.K., Claesson H.-E., Rydell-Tormanen K., Swedmark S., Hallgren A., and Erjefalt J.S. Mice Lacking 12/15-lipoxygenase have attenuated airway allergic inflammation and remodeling. Am J Respir Cell Mol Biol 39 (2008) 648-656
6. Huo Y., Zhao L., Hyman M.C., Shashkin P., Harry B.L., Burcin T., et al. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein e-deficient mice. Circulation 110 (2004) 2024-2031
7. Musk A., Ryan G., Perera D., D'Souza B., Hockey R., and Hobbs M. Mortality from asthma in Western Australia. Med J Aust 147 (1987) 423-427
8. Toren K., and Lindholm N. Do patients with severe asthma run an increased risk from ischaemic heart disease?. Int J Epidemiol 25 (1996) 617-620
9. Knoflach M., Kiechl S., Mayr A., Willeit J., Poewe W., and Wick G. Allergic rhinitis, asthma, and atherosclerosis in the Bruneck and ARMY studies. Arch Intern Med 165 (2005) 2521-2526
10. Schanen J., Iribarren C., Shahar E., Punjabi N., Rich S., Sorlie P., et al. Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study. Thorax 60 (2005) 633-638
11. Onufrak S.J., Abramson J.L., Austin H.D., Holguin F., McClellan W.M., and Vaccarino L.V. Relation of adult-onset asthma to coronary heart disease and stroke. Am J Cardiol 101 (2008) 1247-1252
12. Onufrak S., Abramson J., and Vaccarino V. Adult-onset asthma is associated with increased carotid atherosclerosis among women in the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 195 (2007) 129-137
13. Iribarren C., Tolstykh I., and Eisner M. Are patients with asthma at increased risk of coronary heart disease?. Int J Epidemiol 33 (2004) 743-748
14. Salpeter S., Ormiston T., and Salpeter E. Cardiovascular effects of β-agonists in patients with asthma and COPD: a meta-analysis. Chest 125 (2004) 2309-2321
15. Au D.H., Curtis J.R., Every N.R., McDonell M.B., and Fihn S.D. Association between inhaled β-agonists and the risk of unstable angina and myocardial infarction. Chest 121 (2002) 846-851
16. Au D.H., Lemaitre R.N., Randall Curtis J., Smith N.L., and Psaty B.M. The risk of myocardial infarction associated with inhaled beta -adrenoceptor agonists. Am J Respir Crit Care Med 161 (2000) 827-830
17. Suissa S., Assimes T., and Ernst P. Inhaled short acting β agonist use in COPD and the risk of acute myocardial infarction. Thorax 58 (2003) 43-46
18. Appleton S., Ruffin R., Wilson D., Taylor A., and Adams R. Asthma is associated with cardiovascular disease in a representative population sample. Obes Res Clin Pract 2 (2008) 91-99
19. Martinez F.D. Safety of long-acting beta-agonists-an urgent need to clear the air. N Engl J Med 353 (2005) 2637-2639
20. Nelson H. Long-acting beta-agonists in adult asthma: evidence that these drugs are safe. Prim Care Respir J 15 (2006) 271-277
21. Pearce N., and Hensley M.J. Epidemiologic studies of beta agonists and asthma deaths. Epidemiol Rev 20 (1998) 173-186
22. Grant J., Chittleborough C., Taylor A., Dal Grande E., Wilson D., Phillips P., et al. The North West Adelaide Health Study: detailed methods and baseline segmentation of a cohort for selected chronic diseases. Epidemiol Perspect Innovations 3 (2006) 4
23. Taylor A., Wilson D., and Wakefield M. Differences in health estimates using telephones and door-to-door survey methods-a hypothetical exercise. Aust N Z J Public Health 22 (1998) 223-226
24. Rahman A., Gibney L., Person S., Williams O., Kiefe C., Jolly P., et al. Validity of self-reports of reasons for hospitalization by young adults and risk factors for discordance with medical records. The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 162 (2005) 491-498
25. Kriegsman D., Penninx B., van Eijk J., Boeke A., and Deeg D. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly: a study on the accuracy of patients' self-reports and on determinants of inaccuracy. J Clin Epidemiol 49 (1996) 1407-1417
26. National Cholesterol Education Program, NHLBI. Third report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Full Report (2002), National Institutes of Health, Bethesda (Md)
27. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity (1997), World Health Organization, Geneva
28. American Thoracic Society. Lung function testing: selection of reference values and interpretive strategies. Am Rev Respir Dis 144 (1991) 1202-1218
29. Appleton S., Adams R., Wilson D., Taylor A., Ruffin R., and on behalf of the North West Adelaide Cohort Health Study Team. Spirometric criteria for asthma: adding further evidence to the debate. J Allergy Clin Immunol 116 (2005) 976-982
30. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available at: www.goldcopd.com. Accessed July 15, 2003.
31. Selim A., Ren X., Fincke G., Rogers W., Lee A., and Kazis L. A symptom-based measure of the severity of chronic lung disease: results from the Veterans Health Study. Chest 111 (1997) 1607-1614
32. Frostad A., Soyseth V., Haldorsen T., Andersen A., and Gulsvik A. Respiratory symptoms and long-term cardiovascular mortality. Respir Med 101 (2007) 2289-2296
33. Sin D.D., Wu L., and Man S.F.P. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 127 (2005) 1952-1959
34. Dogra S., Ardern C., and Baker J. The relationship between asthma age of onset and cardiovascular disease in Canadians with asthma. J Asthma 44 (2007) 849-854
35. Hospers J.J., Rijcken B., Schouten J.P., Postma D.S., and Weiss S.T. eosinophilia and positive skin tests predict cardiovascular mortality in a general population sample followed for 30 years. Am J Epidemiol 150 (1999) 482-491
36. Hancox R.J., Aldridge R.E., Cowan J.O., Flannery E.M., Herbison G.P., McLachlan C.R., et al. Tolerance to beta-agonists during acute bronchoconstriction. Eur Respir J 14 (1999) 283-287
37. Suissa S., Assimes T., Brassard P., and Ernst P. Inhaled corticosteroid use in asthma and the prevention of myocardial infarction. Am J Med 115 (2003) 377-381
38. Camargo Jr. C.A., Barr R.G., Chen R., and Speizer F.E. Prospective study of inhaled corticosteroid use, cardiovascular mortality, and all-cause mortality in asthmatic women. Chest 134 (2008) 546-551
39. Lofdahl C.G., Postma D.S., Pride N.B., Boe J., and Thoren A. Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD. Eur Respir J 29 (2007) 1115-1119
40. Huiart L., Ernst P., Ranouil X., and Suissa S. Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD. Eur Respir J 25 (2005) 634-639
41. Adams R., Appleton S., Hill C., Wilson D., Taylor A., Chittleborough C., et al. Independent association of HbA1c and incident cardiovascular disease in people without diabetes. Obesity (2009) In press
42. Jensen-Jarolim E., and Untersmayr E. Gender-medicine aspects in allergology. Allergy 63 (2008) 610-615
43. Real F.G., Svanes C., Omenaas E.R., Antò J.M., Plana E., Janson C., et al. Menstrual irregularity and asthma and lung function. J Allergy Clin Immunol 120 (2007) 557-564
44. Real F.G., Svanes C., Omenaas E.R., Antò J.M., Plana E., Jarvis D., et al. Lung function, respiratory symptoms, and the menopausal transition. J Allergy Clin Immunol 121 (2008) 72-80
45. Zaitsu M., Narita S.-I., Lambert K.C., Grady J.J., Estes D.M., Curran E.M., et al. Estradiol activates mast cells via a non-genomic estrogen receptor-[alpha] and calcium influx. Mol Immunol 44 (2007) 1977-1985
46. Mueller C., Wassmann K., Widder J., Wassmann S., Chen C., Keuler B., et al. Multidrug resistance protein-1 affects oxidative stress, endothelial dysfunction, and atherogenesis via leukotriene C4 export. Circulation 117 (2008) 2912-2918
47. Toren K., Brisman J., and Jarvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest 104 (1993) 600-608
48. Kitch B., Levy B., and Fanta C. Late onset asthma. Epidemiology, diagnosis and treatment. Drugs Aging 17 (2000) 395
49. Australian Centre for Asthma Monitoring. Asthma in Australia: findings from the 2004-05 National Health Survey (2007), Australian Institute of Health and Welfare, Canberra
50. Australian Bureau of Statistics. 2001 Census Basic Community Profile and Snapshot: 405 Adelaide (Statistical Division), Australia, South Australia (2001), Australian Bureau of Statistics, Canberra
51. O'Flaherty M., Ford E., Allender S., Scarborough P., and Capewell S. Coronary heart disease trends in England and Wales from 1984 to 2004: concealed leveling of mortality rates among young adults. Heart 94 (2008) 178-181